Objective
The NOVA_i4SF will establish a Centre of Excellence (CoE) in Human and Environmental Health for a Sustainable Future at NOVA School of Science and Technology (NOVA), in strategic partnership with Leiden University (LU) and Leiden University Medical Center (LUMC). The CoE aims to transform the pharmaceutical industry by pioneering eco-friendly active pharmaceutical ingredients and sustainable processes, thereby significantly reducing environmental impact.
Pharmaceutical pollution is a serious threat to ecosystems and human health, accentuated by pharmaceutical industry emissions and residues. By leveraging advanced research in green solvents, molecular biology, integrative omics, and AI-based tools, with Leiden’s expertise, NOVA_i4SF will address challenges in sustainable (bio)pharmaceuticals. The CoE’s objectives include creating an autonomous research hub, ensuring long-term sustainability through robust funding, building a world-class team, delivering cutting-edge research, and offering specialized training. The project also emphasizes transdisciplinary approaches, forging strong ties with industry, and securing alignment with EU missions. Through Sparkling Research Projects, the CoE will accelerate the discovery of sustainable therapies and pioneer environmentally conscious drug development. A governance structure with dedicated boards will guide NOVA_i4SF’s scientific agenda, with strategic investments fueling new facilities, advanced analytical equipment, and synergy with existing consortia. Empowering NOVA's R&D facilities and Leiden’s global networks, the CoE will drive new research strands and foster industry collaborations, addressing the lack of a centralised hub for sustainable pharmaceutical processes in EU. NOVA_i4SF aspires to serve as a global leader in the design, production, and dissemination of greener, safer pharmaceutical solutions, driving innovation and competitive growth while benefiting society, the environment, and the EU Research Area.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences health sciences public health
- social sciences sociology governance
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- natural sciences biological sciences molecular biology
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.4.1 - Widening participation and spreading excellence
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-WIDERA-2025-ACCESS-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1099-085 Lisboa
Portugal
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.